Logo

Oxford BioDynamics

New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More

New products and services posted to GenomeWeb for the week of Sept. 25, 2023

Oxford BioDynamics to Raise £12.0M in Stock Placement, Offering

The company said it will use the proceeds of the transactions, which are subject to shareholder approval, to advance its EpiSwitch diagnostics platform.

New Products Posted to GenomeWeb: Oxford BioDynamics, Sophia Genetics, NanoString, More

Oxford BioDynamics Awarded Grant to Apply EpiSwitch to ICI Cancer Therapy Response

The two-year PACT grant will fund the application of the EpiSwitch technology to the analysis of primary and acquired ICI resistance in several clinical trials.

Agilent, Oxford BioDynamics Sign Supply, Resale Agreement for Array Kit

Agilent will supply a custom-made SurePrint G3CGH Microarray for Oxford's newly launched Explorer Array Kit, which will include OBD's 3D Genome Probes.

May 5, 2020

Scottish Researchers, Oxford BioDynamics Partner to Identify Epigenetic COVID-19 Biomarkers
Premium

Dec 11, 2019

Oxford BioDynamics Fiscal 2019 Revenues Down 24 Percent

Sep 19, 2019

Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia
Premium

Aug 23, 2019

Singapore's Inex, Nova Satra Merge to Offer Dx Tests for Asian Women

Jun 14, 2019

People in the News: Thomas Schinecker, Amelia Warner, Bartu Ahiska, More

Mar 19, 2019

Oxford Biodynamics Joins UK Prostate Cancer Screening Trial

Dec 12, 2018

Oxford Biodynamics Posts Flat Revenues for FY 2018

Nov 12, 2018

Oxford BioDynamics Forms Autism Biomarker Alliance

Oct 8, 2018

European PEP-NET Consortium Aims to Integrate Epigenetic Data With Mathematical Models
Premium

Aug 22, 2018

Oxford BioDynamics Inks Business Development Partnership for China; Gains $12.6M Investment

Apr 11, 2018

Pfizer, Oxford BioDynamics, U of Glasgow Researchers Develop Approach to Gauge Response to RA Drug
Premium

Jan 29, 2018

Oxford BioDynamics, Holos to Develop Biomarkers for Sports-Related Concussions

Oct 10, 2017

Oxford BioDynamics Advances Epigenetic Signatures for Breast Cancer, ALS
Premium

May 18, 2017

Oxford BioDynamics Licenses EpiSwitch to Nova Satra in Asia

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.